Home /Research /Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
SURGICAL

Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer

Boris Sepesi, Nicolas Zhou, William N. William, Heather Lin, Cheuk Hong Leung, Annikka Weissferdt, K. G. Mitchell, Apar Pataer, Garrett L. Walsh, David C. Rice, Jack A. Roth, Reza J. Mehran, Wayne L. Hofstetter, Mara B. Antonoff, Ravi Rajaram, Marcelo V. Negrão, Anne S. Tsao, Don L. Gibbons, John V. Heymach, Ara A. Vaporciyan

Year
2022
Citations
94

Keywords

NivolumabMedicineIpilimumabPerioperativeLung cancerNeoadjuvant therapySurgeryChemotherapyCancerInternal medicine

Related papers

Browse all SURGICAL papers